Skip to content

Author

S. Hong

We have 2 of 28 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Comparative Cardiovascular Outcomes of Fimasartan and Calcium Channel Blockers in Hypertension: A Nationwide 3-Year Follow-Up Cohort Study

Background: Fimasartan is an angiotensin II receptor blocker (ARB) that was developed in Korea. Although ARBs and calcium channel blockers (CCBs) are both recommended first-line antihypertensive drug classes, real-world outcome data comparing fimasartan specifically with CCBs remain limited. Methods: We analyzed Korean...

Yuran Ahn, Ji-In Lee, Han Saem Jeong et al. · 0 citations
Open access Aug 2026

Substantial Change Between Repeated Lipoprotein(a) Measurements Is Associated with Residual Cardiovascular Risk in a Real-World Multicenter Cohort

Intra-individual change in Lp(a) between two measurements is independently associated with cardiovascular outcomes but provides only modest incremental discrimination, which requires prospective validation before they can inform repeat-testing strategies.

Mi-Na Kim, Dongkuk Kim, S. Hong et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.